BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND DNAJB1, HSPF1, 3337, ENSG00000132002, P25685, Hdj1, Hsp40 AND Treatment
6 results:

  • 1. Comprehensive analysis of the biological functions of endoplasmic reticulum stress in prostate cancer.
    Cen S; Jiang D; Lv D; Xu R; Hou J; Yang Z; Wu P; Xiong X; Gao X
    Front Endocrinol (Lausanne); 2023; 14():1090277. PubMed ID: 36967783
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Andrographolide Analogue 3A.1 Synergizes with Taxane Derivatives in Aggressive Metastatic prostate cancers by Upregulation of Heat Shock Proteins and Downregulation of MAT2A-Mediated Cell Migration and Invasion.
    Mitra Ghosh T; Kansom T; Mazumder S; Davis J; Alnaim AS; Jasper SL; Zhang C; Bird A; Opanasopit P; Mitra AK; Arnold RD
    J Pharmacol Exp Ther; 2022 Mar; 380(3):180-201. PubMed ID: 34949650
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Circulating tumor cells in patients undergoing androgen deprivation therapy with versus without cryosurgery for metastatic prostate cancer: a retrospective analysis.
    Sheng M; Guo S; Liu C
    World J Surg Oncol; 2021 Dec; 19(1):345. PubMed ID: 34903228
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90β and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth.
    Brünnert D; Langer C; Zimmermann L; Bargou RC; Burchardt M; Chatterjee M; Stope MB
    J Cell Biochem; 2020 Jan; 121(1):407-417. PubMed ID: 31222811
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeting the hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant prostate cancer.
    Moses MA; Kim YS; Rivera-Marquez GM; Oshima N; Watson MJ; Beebe KE; Wells C; Lee S; Zuehlke AD; Shao H; Bingman WE; Kumar V; Malhotra SV; Weigel NL; Gestwicki JE; Trepel JB; Neckers LM
    Cancer Res; 2018 Jul; 78(14):4022-4035. PubMed ID: 29764864
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in prostate Tumor Cells Without Induction of a Heat Shock Response.
    Armstrong HK; Koay YC; Irani S; Das R; Nassar ZD; ; Selth LA; Centenera MM; McAlpine SR; Butler LM
    Prostate; 2016 Dec; 76(16):1546-1559. PubMed ID: 27526951
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.